US Patent 11918556 Treatment of circadian rhythm disorders
Patent 11918556 was granted and assigned to Vanda Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11918556 Treatment of circadian rhythm disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
